Connect Biopharma Holdings Limited

NasdaqGM:CNTB Rapporto sulle azioni

Cap. di mercato: US$88.2m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Connect Biopharma Holdings Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Barry Quart

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del management2.8yrs
Durata media del Consiglio di amministrazione3.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Mar 07
Companies Like Connect Biopharma Holdings (NASDAQ:CNTB) Are In A Position To Invest In Growth

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Sep 19
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Invest In Growth?

Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Mar 29
Will Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?

Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Dec 14
Is Connect Biopharma Holdings (NASDAQ:CNTB) In A Good Position To Deliver On Growth Plans?

Market Appears To Relegate Connect Biopharma To A Long-Term Hold

Oct 10

Connect Biopharma Is A Sleeper Heading Into October Data Readout

Sep 26

Connect Biopharma reports 1H results

Sep 13

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Aug 12
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Apr 29
We're Keeping An Eye On Connect Biopharma Holdings' (NASDAQ:CNTB) Cash Burn Rate

Connect Biopharma's Latest Dermatitis Drug Update Fails To Pump Up Shares

Jan 12

We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

Jan 01
We're Hopeful That Connect Biopharma Holdings (NASDAQ:CNTB) Will Use Its Cash Wisely

AMMINISTRATORE DELEGATO

Barry Quart (67 yo)

less than a year

Mandato

Dr. Barry D. Quart, Pharm D., serves as Chief Executive Officer & Director of Connect Biopharma Holdings Limited since June 12, 2024. He had served as Chief Executive Officer of Heron Therapeutics, Inc. si...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Zheng Wei
Co-Founder & Director12.7yrsNessun dato10.76%
$ 9.5m
Wubin Pan
Co-Founder & Directorno dataNessun dato11.25%
$ 9.9m
Steven Chan
Chief Financial Officer2.8yrsNessun dato0.014%
$ 12.0k
Barry Quart
CEO & Directorless than a yearNessun datoNessun dato
David Szekeres
Presidentless than a yearNessun datoNessun dato
Jiang Bian
General Counsel & Chief Compliance Officer3.1yrsNessun datoNessun dato
Lei Sun
VP of Biologics & Head of CMC4.7yrsNessun datoNessun dato
Raul Collazo
VP & Global Head of Medical Affairsno dataNessun datoNessun dato
Srikanth Pendyala
Senior Vice President of Clinical Development(Consultant)less than a yearNessun datoNessun dato

2.8yrs

Durata media

59.5yo

Età media

Gestione esperta: Il team dirigenziale di CNTB è considerato esperto (durata media dell'incarico 2.8 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Zheng Wei
Co-Founder & Director12.7yrsNessun dato10.76%
$ 9.5m
Wubin Pan
Co-Founder & Director12.3yrsNessun dato11.25%
$ 9.9m
Barry Quart
CEO & Directorless than a yearNessun datoNessun dato
Stuart J. Swiedler
Member of Scientific Advisory Board3.7yrsNessun datoNessun dato
Jean I. Liu
Independent Director3.1yrsNessun dato0%
$ 0
Karen Wilson
Independent Non-Executive Director3.8yrsNessun dato0.018%
$ 16.0k
Kleanthis Xanthopoulos
Independent Chairman3.8yrsNessun dato0%
$ 0
Brian Gordon Feagan
Member of Scientific Advisory Board3.7yrsNessun datoNessun dato
David T. Rubin
Member of Scientific Advisory Board3.7yrsNessun datoNessun dato
Emma Guttman-Yassky
Member of Scientific Advisory Board3.7yrsNessun datoNessun dato
Kan Chen
Independent Non-Executive Director3.8yrsNessun datoNessun dato
Edward M. Kerwin
Member of Scientific Advisory Board3.7yrsNessun datoNessun dato

3.7yrs

Durata media

60.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di CNTB sono considerati esperti (durata media dell'incarico 3.6 anni).